Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.78 HKD | -0.42% | -1.24% | -27.02% |
Mar. 22 | Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | China Permits Clinical Trial of Tong Ren Teng's Anti-Blood Stasis Drug | MT |
Business Summary
Number of employees: 4,030
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
The Company
57.6
%
| 3,926 | 60.3 % | 4,012 | 57.6 % | +2.17% |
Tong Ren Tang Chinese Medicine
23.9
%
| 1,556 | 23.9 % | 1,664 | 23.9 % | +6.96% |
All Others
18.5
%
| 1,026 | 15.8 % | 1,292 | 18.5 % | +25.85% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
81.3
%
| 5,377 | 82.6 % | 5,662 | 81.3 % | +5.31% |
International
18.7
%
| 1,132 | 17.4 % | 1,306 | 18.7 % | +15.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jia Fu Chen
CEO | Chief Executive Officer | 55 | 23-06-14 |
Guan Zhao Han
LAW | General Counsel | 45 | - |
Shu Wu Zhao
PRN | Corporate Officer/Principal | 42 | - |
Yijun Li
SEC | Corporate Secretary | 40 | 23-05-03 |
Gui Qin Guo
PRN | Corporate Officer/Principal | 59 | - |
Cun Ying Liu
PRN | Corporate Officer/Principal | 59 | - |
Jian Bai
PRN | Corporate Officer/Principal | 64 | - |
Mei Yee Yung
SEC | Corporate Secretary | - | 23-05-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leung Huel Ting
BRD | Director/Board Member | 70 | 00-10-10 |
Ching Har Chan
BRD | Director/Board Member | 67 | 18-06-11 |
Yuan Jing Zhan
BRD | Director/Board Member | 80 | 18-06-11 |
Tao Jin
BRD | Director/Board Member | 55 | - |
Shu Bing Di
CHM | Chairman | 49 | Jan. 21 |
Zhi Mei Feng
BRD | Director/Board Member | 54 | 21-12-15 |
Li Feng
BRD | Director/Board Member | 48 | 22-12-21 |
Chun Rui Wang
BRD | Director/Board Member | 41 | 23-02-15 |
Jia Fu Chen
CEO | Chief Executive Officer | 55 | 23-06-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 652,080,000 | 0 | 0 | 45.64 % |
Stock B | 1 | 628,704,000 | 584,575,000 ( 92.98 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
318,540,000 | 38.05% | 364,269,602 $ |
Company contact information
Tong Ren Tang Technologies Co., Ltd.
No.20 Nansanhuan Zhonglu Fengtai District
100079, Beijing
+86 10 8763 2888
http://www.tongrentangkj.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.02% | 785M | |
+39.54% | 6.12B | |
-16.47% | 4.44B | |
-10.16% | 3.14B | |
-0.71% | 3.03B | |
-1.06% | 2.57B | |
+40.09% | 1.87B | |
-0.76% | 1.63B | |
-11.19% | 1.62B | |
-12.74% | 1.53B |
- Stock Market
- Equities
- 1666 Stock
- Company Tong Ren Tang Technologies Co. Ltd.